nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—ALOX5—atherosclerosis	0.546	1	CbGaD
Zileuton—CYP2C9—Rosuvastatin—atherosclerosis	0.0339	0.154	CbGbCtD
Zileuton—CYP2C9—Simvastatin—atherosclerosis	0.0315	0.143	CbGbCtD
Zileuton—CYP2C9—Pravastatin—atherosclerosis	0.0309	0.14	CbGbCtD
Zileuton—CYP2C9—Lovastatin—atherosclerosis	0.0309	0.14	CbGbCtD
Zileuton—CYP3A4—Rosuvastatin—atherosclerosis	0.0197	0.0893	CbGbCtD
Zileuton—CYP3A4—Ezetimibe—atherosclerosis	0.0197	0.0893	CbGbCtD
Zileuton—CYP3A4—Simvastatin—atherosclerosis	0.0183	0.083	CbGbCtD
Zileuton—CYP3A4—Pravastatin—atherosclerosis	0.0179	0.0813	CbGbCtD
Zileuton—CYP3A4—Lovastatin—atherosclerosis	0.0179	0.0813	CbGbCtD
Zileuton—Liver disorder—Ezetimibe—atherosclerosis	0.00231	0.0222	CcSEcCtD
Zileuton—Liver disorder—Simvastatin—atherosclerosis	0.0022	0.0212	CcSEcCtD
Zileuton—Liver disorder—Pravastatin—atherosclerosis	0.00199	0.0191	CcSEcCtD
Zileuton—Hepatotoxicity—Niacin—atherosclerosis	0.00178	0.0172	CcSEcCtD
Zileuton—Hypertonia—Rosuvastatin—atherosclerosis	0.00166	0.016	CcSEcCtD
Zileuton—Neck pain—Ezetimibe—atherosclerosis	0.00159	0.0153	CcSEcCtD
Zileuton—Sleep disorder—Rosuvastatin—atherosclerosis	0.00159	0.0153	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Niacin—atherosclerosis	0.00151	0.0146	CcSEcCtD
Zileuton—Vaginal inflammation—Niacin—atherosclerosis	0.00138	0.0132	CcSEcCtD
Zileuton—Vaginal infection—Niacin—atherosclerosis	0.0013	0.0125	CcSEcCtD
Zileuton—Sleep disorder—Simvastatin—atherosclerosis	0.00126	0.0121	CcSEcCtD
Zileuton—Hypertonia—Niacin—atherosclerosis	0.00121	0.0116	CcSEcCtD
Zileuton—Sleep disorder—Pravastatin—atherosclerosis	0.00114	0.0109	CcSEcCtD
Zileuton—Jaundice—Rosuvastatin—atherosclerosis	0.00103	0.00992	CcSEcCtD
Zileuton—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00103	0.0099	CcSEcCtD
Zileuton—Sinusitis—Rosuvastatin—atherosclerosis	0.000992	0.00955	CcSEcCtD
Zileuton—Hepatitis—Rosuvastatin—atherosclerosis	0.00095	0.00914	CcSEcCtD
Zileuton—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000916	0.00882	CcSEcCtD
Zileuton—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000874	0.00841	CcSEcCtD
Zileuton—Urinary tract infection—Lovastatin—atherosclerosis	0.000871	0.00839	CcSEcCtD
Zileuton—Jaundice—Ezetimibe—atherosclerosis	0.000857	0.00825	CcSEcCtD
Zileuton—Sinusitis—Lovastatin—atherosclerosis	0.000841	0.00809	CcSEcCtD
Zileuton—Sinusitis—Ezetimibe—atherosclerosis	0.000825	0.00794	CcSEcCtD
Zileuton—Jaundice—Simvastatin—atherosclerosis	0.000817	0.00787	CcSEcCtD
Zileuton—Flatulence—Rosuvastatin—atherosclerosis	0.000814	0.00784	CcSEcCtD
Zileuton—Hepatitis—Lovastatin—atherosclerosis	0.000805	0.00774	CcSEcCtD
Zileuton—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00079	0.0076	CcSEcCtD
Zileuton—Hepatitis—Ezetimibe—atherosclerosis	0.000789	0.0076	CcSEcCtD
Zileuton—Sinusitis—Simvastatin—atherosclerosis	0.000787	0.00757	CcSEcCtD
Zileuton—Hepatitis—Simvastatin—atherosclerosis	0.000753	0.00724	CcSEcCtD
Zileuton—Jaundice—Niacin—atherosclerosis	0.00075	0.00722	CcSEcCtD
Zileuton—Jaundice—Pravastatin—atherosclerosis	0.000739	0.00711	CcSEcCtD
Zileuton—Urinary tract infection—Pravastatin—atherosclerosis	0.000737	0.00709	CcSEcCtD
Zileuton—Sinusitis—Pravastatin—atherosclerosis	0.000711	0.00684	CcSEcCtD
Zileuton—Myalgia—Rosuvastatin—atherosclerosis	0.000704	0.00677	CcSEcCtD
Zileuton—Arthralgia—Rosuvastatin—atherosclerosis	0.000704	0.00677	CcSEcCtD
Zileuton—Hepatitis—Niacin—atherosclerosis	0.000691	0.00665	CcSEcCtD
Zileuton—Flatulence—Lovastatin—atherosclerosis	0.00069	0.00664	CcSEcCtD
Zileuton—Hepatitis—Pravastatin—atherosclerosis	0.00068	0.00655	CcSEcCtD
Zileuton—Flatulence—Ezetimibe—atherosclerosis	0.000677	0.00652	CcSEcCtD
Zileuton—Ill-defined disorder—Lovastatin—atherosclerosis	0.00065	0.00626	CcSEcCtD
Zileuton—Flatulence—Simvastatin—atherosclerosis	0.000646	0.00621	CcSEcCtD
Zileuton—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000637	0.00614	CcSEcCtD
Zileuton—Malaise—Lovastatin—atherosclerosis	0.000632	0.00608	CcSEcCtD
Zileuton—LTB4R—adipose tissue—atherosclerosis	0.00062	0.125	CbGeAlD
Zileuton—Malaise—Ezetimibe—atherosclerosis	0.00062	0.00596	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000615	0.00592	CcSEcCtD
Zileuton—Insomnia—Rosuvastatin—atherosclerosis	0.00061	0.00587	CcSEcCtD
Zileuton—Ill-defined disorder—Simvastatin—atherosclerosis	0.000608	0.00585	CcSEcCtD
Zileuton—Chest pain—Lovastatin—atherosclerosis	0.000596	0.00574	CcSEcCtD
Zileuton—Arthralgia—Lovastatin—atherosclerosis	0.000596	0.00574	CcSEcCtD
Zileuton—Myalgia—Lovastatin—atherosclerosis	0.000596	0.00574	CcSEcCtD
Zileuton—Dyspepsia—Rosuvastatin—atherosclerosis	0.000594	0.00572	CcSEcCtD
Zileuton—Flatulence—Niacin—atherosclerosis	0.000593	0.00571	CcSEcCtD
Zileuton—Malaise—Simvastatin—atherosclerosis	0.000591	0.00569	CcSEcCtD
Zileuton—Tension—Niacin—atherosclerosis	0.00059	0.00568	CcSEcCtD
Zileuton—Discomfort—Lovastatin—atherosclerosis	0.000589	0.00567	CcSEcCtD
Zileuton—Chest pain—Ezetimibe—atherosclerosis	0.000585	0.00563	CcSEcCtD
Zileuton—Myalgia—Ezetimibe—atherosclerosis	0.000585	0.00563	CcSEcCtD
Zileuton—Arthralgia—Ezetimibe—atherosclerosis	0.000585	0.00563	CcSEcCtD
Zileuton—Nervousness—Niacin—atherosclerosis	0.000584	0.00562	CcSEcCtD
Zileuton—Flatulence—Pravastatin—atherosclerosis	0.000584	0.00562	CcSEcCtD
Zileuton—Tension—Pravastatin—atherosclerosis	0.000581	0.00559	CcSEcCtD
Zileuton—Discomfort—Ezetimibe—atherosclerosis	0.000578	0.00556	CcSEcCtD
Zileuton—Constipation—Rosuvastatin—atherosclerosis	0.000577	0.00555	CcSEcCtD
Zileuton—Pain—Rosuvastatin—atherosclerosis	0.000577	0.00555	CcSEcCtD
Zileuton—Nervousness—Pravastatin—atherosclerosis	0.000575	0.00554	CcSEcCtD
Zileuton—Arthralgia—Simvastatin—atherosclerosis	0.000558	0.00537	CcSEcCtD
Zileuton—Myalgia—Simvastatin—atherosclerosis	0.000558	0.00537	CcSEcCtD
Zileuton—Chest pain—Simvastatin—atherosclerosis	0.000558	0.00537	CcSEcCtD
Zileuton—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000556	0.00535	CcSEcCtD
Zileuton—Discomfort—Simvastatin—atherosclerosis	0.000551	0.0053	CcSEcCtD
Zileuton—Ill-defined disorder—Pravastatin—atherosclerosis	0.00055	0.00529	CcSEcCtD
Zileuton—Urticaria—Rosuvastatin—atherosclerosis	0.000536	0.00516	CcSEcCtD
Zileuton—Malaise—Pravastatin—atherosclerosis	0.000534	0.00514	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000521	0.00501	CcSEcCtD
Zileuton—Insomnia—Lovastatin—atherosclerosis	0.000517	0.00498	CcSEcCtD
Zileuton—Arthralgia—Niacin—atherosclerosis	0.000512	0.00493	CcSEcCtD
Zileuton—Myalgia—Niacin—atherosclerosis	0.000512	0.00493	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000511	0.00492	CcSEcCtD
Zileuton—Insomnia—Ezetimibe—atherosclerosis	0.000507	0.00488	CcSEcCtD
Zileuton—Arthralgia—Pravastatin—atherosclerosis	0.000504	0.00485	CcSEcCtD
Zileuton—Chest pain—Pravastatin—atherosclerosis	0.000504	0.00485	CcSEcCtD
Zileuton—Myalgia—Pravastatin—atherosclerosis	0.000504	0.00485	CcSEcCtD
Zileuton—Dyspepsia—Lovastatin—atherosclerosis	0.000503	0.00484	CcSEcCtD
Zileuton—Discomfort—Pravastatin—atherosclerosis	0.000498	0.0048	CcSEcCtD
Zileuton—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000497	0.00478	CcSEcCtD
Zileuton—Dyspepsia—Ezetimibe—atherosclerosis	0.000494	0.00475	CcSEcCtD
Zileuton—Constipation—Lovastatin—atherosclerosis	0.000489	0.00471	CcSEcCtD
Zileuton—Pain—Lovastatin—atherosclerosis	0.000489	0.00471	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000487	0.00469	CcSEcCtD
Zileuton—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000484	0.00466	CcSEcCtD
Zileuton—Insomnia—Simvastatin—atherosclerosis	0.000484	0.00465	CcSEcCtD
Zileuton—Constipation—Ezetimibe—atherosclerosis	0.00048	0.00461	CcSEcCtD
Zileuton—Pain—Ezetimibe—atherosclerosis	0.00048	0.00461	CcSEcCtD
Zileuton—Pruritus—Rosuvastatin—atherosclerosis	0.000477	0.00459	CcSEcCtD
Zileuton—Feeling abnormal—Lovastatin—atherosclerosis	0.000471	0.00453	CcSEcCtD
Zileuton—Dyspepsia—Simvastatin—atherosclerosis	0.000471	0.00453	CcSEcCtD
Zileuton—Feeling abnormal—Ezetimibe—atherosclerosis	0.000462	0.00445	CcSEcCtD
Zileuton—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000462	0.00444	CcSEcCtD
Zileuton—Diarrhoea—Rosuvastatin—atherosclerosis	0.000462	0.00444	CcSEcCtD
Zileuton—Constipation—Simvastatin—atherosclerosis	0.000457	0.0044	CcSEcCtD
Zileuton—Pain—Simvastatin—atherosclerosis	0.000457	0.0044	CcSEcCtD
Zileuton—EPHX2—adipose tissue—atherosclerosis	0.000456	0.0923	CbGeAlD
Zileuton—Urticaria—Lovastatin—atherosclerosis	0.000454	0.00437	CcSEcCtD
Zileuton—Body temperature increased—Lovastatin—atherosclerosis	0.000452	0.00435	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000447	0.00431	CcSEcCtD
Zileuton—Dizziness—Rosuvastatin—atherosclerosis	0.000446	0.00429	CcSEcCtD
Zileuton—Urticaria—Ezetimibe—atherosclerosis	0.000445	0.00429	CcSEcCtD
Zileuton—Insomnia—Niacin—atherosclerosis	0.000444	0.00427	CcSEcCtD
Zileuton—Body temperature increased—Ezetimibe—atherosclerosis	0.000443	0.00427	CcSEcCtD
Zileuton—Feeling abnormal—Simvastatin—atherosclerosis	0.000441	0.00424	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00044	0.00424	CcSEcCtD
Zileuton—Insomnia—Pravastatin—atherosclerosis	0.000437	0.00421	CcSEcCtD
Zileuton—Somnolence—Niacin—atherosclerosis	0.000437	0.0042	CcSEcCtD
Zileuton—LTB4R—liver—atherosclerosis	0.000435	0.088	CbGeAlD
Zileuton—Dyspepsia—Niacin—atherosclerosis	0.000432	0.00416	CcSEcCtD
Zileuton—Dyspepsia—Pravastatin—atherosclerosis	0.000426	0.0041	CcSEcCtD
Zileuton—Rash—Rosuvastatin—atherosclerosis	0.000425	0.00409	CcSEcCtD
Zileuton—Dermatitis—Rosuvastatin—atherosclerosis	0.000425	0.00409	CcSEcCtD
Zileuton—Urticaria—Simvastatin—atherosclerosis	0.000425	0.00409	CcSEcCtD
Zileuton—Gastrointestinal disorder—Niacin—atherosclerosis	0.000424	0.00408	CcSEcCtD
Zileuton—Body temperature increased—Simvastatin—atherosclerosis	0.000423	0.00407	CcSEcCtD
Zileuton—Headache—Rosuvastatin—atherosclerosis	0.000423	0.00407	CcSEcCtD
Zileuton—Hypersensitivity—Lovastatin—atherosclerosis	0.000421	0.00405	CcSEcCtD
Zileuton—Pain—Niacin—atherosclerosis	0.00042	0.00404	CcSEcCtD
Zileuton—Pain—Pravastatin—atherosclerosis	0.000413	0.00398	CcSEcCtD
Zileuton—Constipation—Pravastatin—atherosclerosis	0.000413	0.00398	CcSEcCtD
Zileuton—Hypersensitivity—Ezetimibe—atherosclerosis	0.000413	0.00398	CcSEcCtD
Zileuton—Pruritus—Lovastatin—atherosclerosis	0.000404	0.00389	CcSEcCtD
Zileuton—Nausea—Rosuvastatin—atherosclerosis	0.000401	0.00386	CcSEcCtD
Zileuton—Feeling abnormal—Pravastatin—atherosclerosis	0.000398	0.00383	CcSEcCtD
Zileuton—Pruritus—Ezetimibe—atherosclerosis	0.000397	0.00382	CcSEcCtD
Zileuton—Hypersensitivity—Simvastatin—atherosclerosis	0.000394	0.00379	CcSEcCtD
Zileuton—Diarrhoea—Lovastatin—atherosclerosis	0.000391	0.00376	CcSEcCtD
Zileuton—Urticaria—Niacin—atherosclerosis	0.00039	0.00375	CcSEcCtD
Zileuton—Body temperature increased—Niacin—atherosclerosis	0.000388	0.00374	CcSEcCtD
Zileuton—Urticaria—Pravastatin—atherosclerosis	0.000384	0.0037	CcSEcCtD
Zileuton—Diarrhoea—Ezetimibe—atherosclerosis	0.000384	0.00369	CcSEcCtD
Zileuton—Body temperature increased—Pravastatin—atherosclerosis	0.000382	0.00368	CcSEcCtD
Zileuton—Pruritus—Simvastatin—atherosclerosis	0.000378	0.00364	CcSEcCtD
Zileuton—Dizziness—Lovastatin—atherosclerosis	0.000378	0.00364	CcSEcCtD
Zileuton—Dizziness—Ezetimibe—atherosclerosis	0.000371	0.00357	CcSEcCtD
Zileuton—Diarrhoea—Simvastatin—atherosclerosis	0.000366	0.00352	CcSEcCtD
Zileuton—Vomiting—Lovastatin—atherosclerosis	0.000363	0.0035	CcSEcCtD
Zileuton—Hypersensitivity—Niacin—atherosclerosis	0.000362	0.00348	CcSEcCtD
Zileuton—Rash—Lovastatin—atherosclerosis	0.00036	0.00347	CcSEcCtD
Zileuton—Dermatitis—Lovastatin—atherosclerosis	0.00036	0.00347	CcSEcCtD
Zileuton—Headache—Lovastatin—atherosclerosis	0.000358	0.00345	CcSEcCtD
Zileuton—PTGS1—artery—atherosclerosis	0.000358	0.0724	CbGeAlD
Zileuton—Vomiting—Ezetimibe—atherosclerosis	0.000357	0.00343	CcSEcCtD
Zileuton—Hypersensitivity—Pravastatin—atherosclerosis	0.000356	0.00343	CcSEcCtD
Zileuton—ALOX5—connective tissue—atherosclerosis	0.000356	0.0721	CbGeAlD
Zileuton—Dizziness—Simvastatin—atherosclerosis	0.000354	0.0034	CcSEcCtD
Zileuton—Rash—Ezetimibe—atherosclerosis	0.000354	0.0034	CcSEcCtD
Zileuton—Dermatitis—Ezetimibe—atherosclerosis	0.000353	0.0034	CcSEcCtD
Zileuton—Headache—Ezetimibe—atherosclerosis	0.000351	0.00338	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—atherosclerosis	0.000348	1	CrCbGaD
Zileuton—Pruritus—Niacin—atherosclerosis	0.000347	0.00334	CcSEcCtD
Zileuton—Pruritus—Pravastatin—atherosclerosis	0.000342	0.00329	CcSEcCtD
Zileuton—Vomiting—Simvastatin—atherosclerosis	0.00034	0.00327	CcSEcCtD
Zileuton—Nausea—Lovastatin—atherosclerosis	0.00034	0.00327	CcSEcCtD
Zileuton—Rash—Simvastatin—atherosclerosis	0.000337	0.00324	CcSEcCtD
Zileuton—Dermatitis—Simvastatin—atherosclerosis	0.000337	0.00324	CcSEcCtD
Zileuton—Diarrhoea—Niacin—atherosclerosis	0.000336	0.00323	CcSEcCtD
Zileuton—Headache—Simvastatin—atherosclerosis	0.000335	0.00322	CcSEcCtD
Zileuton—Nausea—Ezetimibe—atherosclerosis	0.000333	0.00321	CcSEcCtD
Zileuton—Diarrhoea—Pravastatin—atherosclerosis	0.000331	0.00318	CcSEcCtD
Zileuton—Dizziness—Niacin—atherosclerosis	0.000325	0.00312	CcSEcCtD
Zileuton—EPHX2—liver—atherosclerosis	0.00032	0.0647	CbGeAlD
Zileuton—Dizziness—Pravastatin—atherosclerosis	0.00032	0.00308	CcSEcCtD
Zileuton—Nausea—Simvastatin—atherosclerosis	0.000318	0.00306	CcSEcCtD
Zileuton—Vomiting—Niacin—atherosclerosis	0.000312	0.003	CcSEcCtD
Zileuton—ALOX5—cardiovascular system—atherosclerosis	0.00031	0.0627	CbGeAlD
Zileuton—Rash—Niacin—atherosclerosis	0.00031	0.00298	CcSEcCtD
Zileuton—Dermatitis—Niacin—atherosclerosis	0.000309	0.00298	CcSEcCtD
Zileuton—Headache—Niacin—atherosclerosis	0.000308	0.00296	CcSEcCtD
Zileuton—Vomiting—Pravastatin—atherosclerosis	0.000307	0.00296	CcSEcCtD
Zileuton—Rash—Pravastatin—atherosclerosis	0.000305	0.00293	CcSEcCtD
Zileuton—Dermatitis—Pravastatin—atherosclerosis	0.000305	0.00293	CcSEcCtD
Zileuton—Headache—Pravastatin—atherosclerosis	0.000303	0.00291	CcSEcCtD
Zileuton—PTGS1—endothelium—atherosclerosis	0.000302	0.0612	CbGeAlD
Zileuton—UGT1A9—liver—atherosclerosis	0.000292	0.0592	CbGeAlD
Zileuton—Nausea—Niacin—atherosclerosis	0.000292	0.00281	CcSEcCtD
Zileuton—Nausea—Pravastatin—atherosclerosis	0.000287	0.00276	CcSEcCtD
Zileuton—PTGS1—blood vessel—atherosclerosis	0.000279	0.0564	CbGeAlD
Zileuton—ALOX5—adipose tissue—atherosclerosis	0.000273	0.0553	CbGeAlD
Zileuton—ALOX5—liver—atherosclerosis	0.000192	0.0388	CbGeAlD
Zileuton—PTGS1—connective tissue—atherosclerosis	0.000143	0.0289	CbGeAlD
Zileuton—CYP2C9—cardiovascular system—atherosclerosis	0.000136	0.0276	CbGeAlD
Zileuton—PTGS1—cardiovascular system—atherosclerosis	0.000124	0.0252	CbGeAlD
Zileuton—PTGS1—adipose tissue—atherosclerosis	0.00011	0.0222	CbGeAlD
Zileuton—CYP1A2—liver—atherosclerosis	8.87e-05	0.018	CbGeAlD
Zileuton—CYP2C9—liver—atherosclerosis	8.42e-05	0.017	CbGeAlD
Zileuton—CYP3A4—liver—atherosclerosis	6.42e-05	0.013	CbGeAlD
Zileuton—UGT1A9—Metabolism—SCARB1—atherosclerosis	1.76e-05	0.000142	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.76e-05	0.000142	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALOX5—atherosclerosis	1.74e-05	0.000141	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—atherosclerosis	1.74e-05	0.000141	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.72e-05	0.000139	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.72e-05	0.000139	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.72e-05	0.000139	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.7e-05	0.000137	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLTP—atherosclerosis	1.69e-05	0.000137	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—HMGCR—atherosclerosis	1.66e-05	0.000135	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—atherosclerosis	1.66e-05	0.000134	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CG—atherosclerosis	1.65e-05	0.000134	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NFKB1—atherosclerosis	1.64e-05	0.000133	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK8—atherosclerosis	1.61e-05	0.00013	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.61e-05	0.00013	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AKT1—atherosclerosis	1.61e-05	0.00013	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.6e-05	0.000129	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPARG—atherosclerosis	1.6e-05	0.000129	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.57e-05	0.000127	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—INS—atherosclerosis	1.57e-05	0.000127	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NAMPT—atherosclerosis	1.56e-05	0.000126	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.56e-05	0.000126	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.56e-05	0.000126	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—LIPC—atherosclerosis	1.55e-05	0.000126	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.55e-05	0.000125	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOC3—atherosclerosis	1.54e-05	0.000125	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—LDLR—atherosclerosis	1.54e-05	0.000124	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.51e-05	0.000122	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.5e-05	0.000121	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CETP—atherosclerosis	1.5e-05	0.000121	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—atherosclerosis	1.49e-05	0.00012	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ABCA1—atherosclerosis	1.48e-05	0.00012	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—atherosclerosis	1.47e-05	0.000119	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCG8—atherosclerosis	1.47e-05	0.000119	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LTA4H—atherosclerosis	1.47e-05	0.000119	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.45e-05	0.000117	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—atherosclerosis	1.44e-05	0.000116	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SCARB1—atherosclerosis	1.44e-05	0.000116	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.43e-05	0.000115	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK3—atherosclerosis	1.41e-05	0.000114	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.4e-05	0.000113	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.39e-05	0.000112	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—NOS3—atherosclerosis	1.37e-05	0.000111	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.37e-05	0.000111	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—atherosclerosis	1.37e-05	0.00011	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.36e-05	0.00011	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—HMGCR—atherosclerosis	1.36e-05	0.00011	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLTP—atherosclerosis	1.31e-05	0.000106	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FABP4—atherosclerosis	1.28e-05	0.000103	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LCAT—atherosclerosis	1.28e-05	0.000103	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—HMOX1—atherosclerosis	1.27e-05	0.000103	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—atherosclerosis	1.26e-05	0.000102	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOA4—atherosclerosis	1.25e-05	0.000101	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.23e-05	9.95e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.22e-05	9.89e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.22e-05	9.86e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOB—atherosclerosis	1.22e-05	9.85e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCA1—atherosclerosis	1.21e-05	9.77e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTM1—atherosclerosis	1.19e-05	9.58e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.17e-05	9.48e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—LPL—atherosclerosis	1.16e-05	9.41e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.16e-05	9.38e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.14e-05	9.2e-05	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—atherosclerosis	1.14e-05	9.18e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GPX1—atherosclerosis	1.14e-05	9.18e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.13e-05	9.16e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.13e-05	9.16e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.12e-05	9.05e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CD36—atherosclerosis	1.11e-05	8.94e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.09e-05	8.83e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FABP4—atherosclerosis	1.09e-05	8.82e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LCAT—atherosclerosis	1.09e-05	8.82e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOA2—atherosclerosis	1.08e-05	8.72e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.08e-05	8.72e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.08e-05	8.72e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.08e-05	8.72e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOA4—atherosclerosis	1.07e-05	8.65e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.07e-05	8.61e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.06e-05	8.6e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.05e-05	8.5e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—MTHFR—atherosclerosis	1.05e-05	8.47e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—HMOX1—atherosclerosis	1.04e-05	8.39e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—atherosclerosis	1.03e-05	8.32e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LPA—atherosclerosis	1.03e-05	8.32e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARA—atherosclerosis	1.03e-05	8.31e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1e-05	8.1e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BGN—atherosclerosis	9.96e-06	8.05e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AGT—atherosclerosis	9.96e-06	8.05e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOB—atherosclerosis	9.93e-06	8.03e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.89e-06	8e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOA5—atherosclerosis	9.86e-06	7.97e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOE—atherosclerosis	9.75e-06	7.89e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP27A1—atherosclerosis	9.72e-06	7.86e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—atherosclerosis	9.66e-06	7.81e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CAV1—atherosclerosis	9.66e-06	7.81e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOA1—atherosclerosis	9.64e-06	7.8e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.58e-06	7.75e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.57e-06	7.74e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	9.49e-06	7.68e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—atherosclerosis	9.49e-06	7.68e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—LPL—atherosclerosis	9.49e-06	7.67e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.39e-06	7.59e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.34e-06	7.55e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.3e-06	7.52e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.28e-06	7.5e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPX1—atherosclerosis	9.26e-06	7.48e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOA2—atherosclerosis	9.21e-06	7.45e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	9.21e-06	7.45e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALOX15—atherosclerosis	9.21e-06	7.45e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	9.21e-06	7.45e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.17e-06	7.41e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCG5—atherosclerosis	9.1e-06	7.36e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.09e-06	7.35e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CD36—atherosclerosis	9.01e-06	7.29e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.95e-06	7.24e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—atherosclerosis	8.8e-06	7.12e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LPA—atherosclerosis	8.79e-06	7.11e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—MTHFR—atherosclerosis	8.54e-06	6.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BGN—atherosclerosis	8.51e-06	6.88e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARG—atherosclerosis	8.5e-06	6.87e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.47e-06	6.85e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.45e-06	6.83e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOA5—atherosclerosis	8.43e-06	6.81e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FABP4—atherosclerosis	8.42e-06	6.8e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LCAT—atherosclerosis	8.42e-06	6.8e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARA—atherosclerosis	8.38e-06	6.77e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—INS—atherosclerosis	8.33e-06	6.74e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOA4—atherosclerosis	8.26e-06	6.68e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.22e-06	6.65e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.19e-06	6.62e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.18e-06	6.61e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LIPC—atherosclerosis	8.17e-06	6.61e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOC3—atherosclerosis	8.12e-06	6.57e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.12e-06	6.56e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AGT—atherosclerosis	8.12e-06	6.56e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	8.11e-06	6.56e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LDLR—atherosclerosis	8.07e-06	6.53e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.02e-06	6.48e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOE—atherosclerosis	7.95e-06	6.43e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.95e-06	6.43e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.93e-06	6.41e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CETP—atherosclerosis	7.88e-06	6.37e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CAV1—atherosclerosis	7.88e-06	6.37e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOA1—atherosclerosis	7.86e-06	6.36e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.84e-06	6.33e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—atherosclerosis	7.64e-06	6.18e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.55e-06	6.1e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.5e-06	6.07e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.35e-06	5.94e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NOS3—atherosclerosis	7.31e-06	5.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.24e-06	5.85e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—atherosclerosis	7.18e-06	5.8e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.13e-06	5.76e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.11e-06	5.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.11e-06	5.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.11e-06	5.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOA2—atherosclerosis	7.11e-06	5.75e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NAMPT—atherosclerosis	7.03e-06	5.68e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.02e-06	5.68e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.99e-06	5.65e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LIPC—atherosclerosis	6.98e-06	5.65e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOC3—atherosclerosis	6.94e-06	5.61e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARG—atherosclerosis	6.93e-06	5.6e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LDLR—atherosclerosis	6.9e-06	5.58e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—INS—atherosclerosis	6.79e-06	5.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LPA—atherosclerosis	6.78e-06	5.48e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CETP—atherosclerosis	6.74e-06	5.45e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—atherosclerosis	6.68e-06	5.4e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BGN—atherosclerosis	6.57e-06	5.31e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOA5—atherosclerosis	6.5e-06	5.26e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.45e-06	5.22e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.43e-06	5.2e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.36e-06	5.14e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—atherosclerosis	6.32e-06	5.11e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.28e-06	5.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.26e-06	5.06e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—atherosclerosis	6.23e-06	5.04e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HMGCR—atherosclerosis	6.09e-06	4.93e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.05e-06	4.89e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NOS3—atherosclerosis	5.96e-06	4.82e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.5e-06	4.44e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.45e-06	4.41e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—atherosclerosis	5.45e-06	4.4e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.43e-06	4.39e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.42e-06	4.38e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LIPC—atherosclerosis	5.39e-06	4.36e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOC3—atherosclerosis	5.36e-06	4.33e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LDLR—atherosclerosis	5.32e-06	4.3e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOB—atherosclerosis	5.22e-06	4.22e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CETP—atherosclerosis	5.2e-06	4.2e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.08e-06	4.11e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LPL—atherosclerosis	4.99e-06	4.03e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.98e-06	4.03e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPX1—atherosclerosis	4.87e-06	3.93e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CD36—atherosclerosis	4.74e-06	3.83e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.7e-06	3.8e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.66e-06	3.77e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.49e-06	3.63e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOB—atherosclerosis	4.46e-06	3.61e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARA—atherosclerosis	4.41e-06	3.56e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.34e-06	3.51e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AGT—atherosclerosis	4.27e-06	3.45e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LPL—atherosclerosis	4.26e-06	3.45e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.19e-06	3.39e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOE—atherosclerosis	4.18e-06	3.38e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX1—atherosclerosis	4.16e-06	3.36e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CAV1—atherosclerosis	4.14e-06	3.35e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOA1—atherosclerosis	4.13e-06	3.34e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CD36—atherosclerosis	4.05e-06	3.27e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.84e-06	3.1e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.77e-06	3.05e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARA—atherosclerosis	3.76e-06	3.04e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AGT—atherosclerosis	3.65e-06	2.95e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARG—atherosclerosis	3.64e-06	2.94e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.6e-06	2.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOE—atherosclerosis	3.57e-06	2.89e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—INS—atherosclerosis	3.57e-06	2.89e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CAV1—atherosclerosis	3.54e-06	2.86e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOA1—atherosclerosis	3.53e-06	2.85e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOB—atherosclerosis	3.44e-06	2.78e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—atherosclerosis	3.36e-06	2.72e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.35e-06	2.71e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LPL—atherosclerosis	3.29e-06	2.66e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—atherosclerosis	3.27e-06	2.65e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.22e-06	2.61e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX1—atherosclerosis	3.21e-06	2.59e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NOS3—atherosclerosis	3.13e-06	2.53e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CD36—atherosclerosis	3.12e-06	2.53e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARG—atherosclerosis	3.11e-06	2.52e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—INS—atherosclerosis	3.05e-06	2.47e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.96e-06	2.39e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARA—atherosclerosis	2.91e-06	2.35e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.86e-06	2.32e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AGT—atherosclerosis	2.81e-06	2.27e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—atherosclerosis	2.8e-06	2.26e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOE—atherosclerosis	2.76e-06	2.23e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—atherosclerosis	2.74e-06	2.21e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CAV1—atherosclerosis	2.73e-06	2.21e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOA1—atherosclerosis	2.73e-06	2.2e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NOS3—atherosclerosis	2.68e-06	2.16e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.49e-06	2.01e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.45e-06	1.98e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARG—atherosclerosis	2.4e-06	1.94e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—INS—atherosclerosis	2.36e-06	1.9e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—atherosclerosis	2.16e-06	1.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NOS3—atherosclerosis	2.07e-06	1.67e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.89e-06	1.53e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—atherosclerosis	1.44e-06	1.16e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—atherosclerosis	1.23e-06	9.95e-06	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—atherosclerosis	9.49e-07	7.68e-06	CbGpPWpGaD
